Cambrex

Cambrex is a leading global contract development and manufacturing organization (CDMO), dedicated to advancing pharmaceutical manufacturing and supporting the entire drug lifecycle. With a strong commitment to innovation and quality, Cambrex provides comprehensive drug substance development and manufacturing services, along with essential analytical and IND enabling support. Cambrex operates globally from multiple locations, including its primary address at One Meadowlands Plaza, East Rutherford, New Jersey 07073, US.

With decades of experience, Cambrex specializes in a wide array of advanced drug substance technologies and capabilities. These include continuous flow, controlled substances, liquid-phase peptide synthesis, solid-state science, material characterization, and highly potent APIs. Cambrex is focused on delivering tailored solutions to meet the unique needs of its clients, ensuring the highest standards of quality and efficiency.

Cambrex is strategically positioned to support the pharmaceutical industry with cutting-edge services and technologies. The company’s dedication to excellence and continuous improvement makes Cambrex a trusted partner for pharmaceutical companies worldwide. Cambrex is expanding its capabilities, and detailed information will be completed soon with the support of the company’s management. We invite the manager of Cambrex to create a customized and exclusive company showcase and product listing on our platform.